Alam John J
EVP, Med. Dev. Group & CMO at VRTX
- Sold, on record
- $4.6M
- Dollars the filings state
- Form 4 sales
- 29
- Latest Oct 1, 2008
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VRTXVERTEX PHARMACEUTICALS INC / MAEVP, Med. Dev. Group & CMO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale VRTXPlan not statedNov 16 2007
Sold 1 shares at $25.82 ($26)
Alam John J, EVP, Medicines Dev. & CMO
Sold 0% of holdings ($3.1M position)119,324 shares left0x usual sizeFiling
- 2 Form 4 sale VRTXPlan not statedDec 11 +25 days
Sold 480 shares at $25.62 ($12k)
Alam John J, EVP, Medicines Dev. & CMO
Sold 0.4% of holdings ($3.1M position)118,844 shares left0.3x usual sizeFiling
- 3 Form 4 sale VRTXPlan not statedMay 21 +162 days
Sold 802 shares at $27.62 ($22k)
Alam John J, EVP, Med. Dev. Group & CMO
Sold 0.6% of holdings ($3.6M position)128,511 shares left0.5x usual sizeFiling
- 4 Form 4 sale VRTXUnusualAug 20 +91 days
Sold 6,612 shares at $27.57 ($182k)
Alam John J, EVP, Med. Dev. Group & CMO
Sold 4.6% of holdings ($4M position)136,792 shares left4.4x usual sizeFiling
- 5 Form 4 sale VRTXUnusualAug 27 +7 days
Sold 6,612 shares at $27.02 ($179k)
Alam John J, EVP, Med. Dev. Group & CMO
Sold 4.6% of holdings ($3.9M position)136,792 shares left4.4x usual sizeFiling
- 6 Form 4 sale VRTXUnusualSep 3 +7 days
Sold 6,612 shares at $25.86 ($171k)
Alam John J, EVP, Med. Dev. Group & CMO
Sold 4.6% of holdings ($3.7M position)136,792 shares left4.4x usual sizeFiling
- 7 Form 4 sale VRTXUnusualSep 10 +7 days
Sold 6,614 shares at $26.23 ($173k)
Alam John J, EVP, Med. Dev. Group & CMO
Sold 4.6% of holdings ($3.8M position)136,792 shares left4.4x usual sizeFiling
- 8 Form 4 sale VRTXPlan not statedOct 1 +21 days
Sold 4,253 shares at $32.65 ($139k)
Alam John J, EVP, Med. Dev. Group & CMO
Sold 3% of holdings ($4.6M position)136,792 shares left2.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (29)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2008 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 4,253 | $139k | 3.0% | Plan not stated | SEC |
| Sep 10, 2008 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 6,614 | $173k | 4.6% | Unusual | SEC |
| Sep 3, 2008 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 6,612 | $171k | 4.6% | Unusual | SEC |
| Aug 27, 2008 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 6,612 | $179k | 4.6% | Unusual | SEC |
| Aug 20, 2008 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 6,612 | $182k | 4.6% | Unusual | SEC |
| May 21, 2008 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 802 | $22k | 0.6% | Plan not stated | SEC |
| Dec 11, 2007 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 480 | $12k | 0.4% | Plan not stated | SEC |
| Nov 16, 2007 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 1 | $26 | 0.0% | Plan not stated | SEC |
| Aug 6, 2007 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 30,720 | $1.1M | 20.5% | Unusual | SEC |
| May 17, 2007 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 794 | $25k | 0.7% | Plan not stated | SEC |
| May 7, 2007 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 32,500 | $994k | 24.0% | Unusual | SEC |
| Jan 31, 2007 | VRTX | EVP, Medicines Dev., & CMO | Form 4 sale | 1,500 | $53k | 1.1% | Plan not stated | SEC |
| Jan 24, 2007 | VRTX | EVP, Med. Product Dev. & CMO | Form 4 sale | 1,500 | $54k | 1.1% | Plan not stated | SEC |
| Jan 17, 2007 | VRTX | EVP, Medicines Dev., & CMO | Form 4 sale | 1,500 | $57k | 1.4% | Plan not stated | SEC |
| Jan 10, 2007 | VRTX | EVP, Medicines Dev., & CMO | Form 4 sale | 1,500 | $53k | 1.4% | Plan not stated | SEC |
| Jan 3, 2007 | VRTX | SVP, Drug Eval. & Appr. | Form 4 sale | 1,500 | $56k | 1.4% | Plan not stated | SEC |
| Dec 27, 2006 | VRTX | SVP, Drug Eval. & Appr. | Form 4 sale | 1,500 | $56k | 1.4% | Plan not stated | SEC |
| Dec 20, 2006 | VRTX | SVP, Drug Eval. & Appr. | Form 4 sale | 1,500 | $57k | 1.4% | Plan not stated | SEC |
| Dec 13, 2006 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 1,980 | $76k | 1.9% | Plan not stated | SEC |
| Dec 6, 2006 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 1,500 | $67k | 1.4% | Plan not stated | SEC |
| Nov 29, 2006 | VRTX | EVP, Medicines Dev. & CMO | Form 4 sale | 1,500 | $66k | 1.4% | Plan not stated | SEC |
| Nov 22, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 1,500 | $67k | 1.4% | Plan not stated | SEC |
| Nov 15, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 2,207 | $96k | 2.1% | Plan not stated | SEC |
| Nov 8, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 1,500 | $62k | 1.4% | Plan not stated | SEC |
| Nov 1, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 3,000 | $121k | 2.8% | Plan not stated | SEC |
| Oct 18, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 1,500 | $54k | 1.4% | Plan not stated | SEC |
| Oct 11, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 7,500 | $265k | 6.7% | Plan not stated | SEC |
| Sep 6, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 1,500 | $53k | 1.4% | Plan not stated | SEC |
| Aug 30, 2006 | VRTX | EVP, Med. Dev. Group & CMO | Form 4 sale | 7,500 | $263k | 6.7% | Plan not stated | SEC |